Company Executives of Insight Molecular Diagnostics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
129.49K
+24.97%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
38.37K
--
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
31.45K
+85.66%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
28.51K
+94.51%
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Andrea S. James
Ms. Andrea S. James
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
129.49K
+24.97%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
38.37K
--
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
31.45K
+85.66%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
28.51K
+94.51%
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
FAQs
Who are the top five shareholders of Insight Molecular Diagnostics Ord Shs?
The top five shareholders of Insight Molecular Diagnostics Ord Shs are: Mr. Andrew (Andy) Arno
What is the biggest source of revenue for Insight Molecular Diagnostics Ord Shs?
In 2026Q4, the Pharma Services business generated the highest revenue for Insight Molecular Diagnostics Ord Shs, amounting to 4.01M and accounting for 99.00% of total revenue.